D.E. Shaw & Co’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.1M | Buy |
1,176,711
+596,050
| +103% | +$4.1M | 0.01% | 1175 |
|
|
2025
Q1 | $1.67M | Sell |
580,661
-2,542
| -0.4% | -$7.32K | ﹤0.01% | 1932 |
|
|
2024
Q4 | $2.74M | Sell |
583,203
-174,528
| -23% | -$820K | ﹤0.01% | 1635 |
|
|
2024
Q3 | $2.71M | Buy |
757,731
+165,946
| +28% | +$592K | ﹤0.01% | 1627 |
|
|
2024
Q2 | $3.67M | Sell |
591,785
-33,391
| -5% | -$207K | ﹤0.01% | 1428 |
|
|
2024
Q1 | $5.9M | Buy |
625,176
+127,497
| +26% | +$1.2M | 0.01% | 1197 |
|
|
2023
Q4 | $3.36M | Buy |
497,679
+276,415
| +125% | +$1.87M | ﹤0.01% | 1459 |
|
|
2023
Q3 | $982K | Buy |
221,264
+75,042
| +51% | +$333K | ﹤0.01% | 2042 |
|
|
2023
Q2 | $483K | Buy |
146,222
+130,899
| +854% | +$432K | ﹤0.01% | 2352 |
|
|
2023
Q1 | $43.7K | Sell |
15,323
-160,823
| -91% | -$458K | ﹤0.01% | 2951 |
|
|
2022
Q4 | $1.28M | Buy |
176,146
+93,807
| +114% | +$683K | ﹤0.01% | 2285 |
|
|
2022
Q3 | $666K | Sell |
82,339
-57,143
| -41% | -$462K | ﹤0.01% | 2743 |
|
|
2022
Q2 | $683K | Sell |
139,482
-407,922
| -75% | -$2M | ﹤0.01% | 2880 |
|
|
2022
Q1 | $12.9M | Sell |
547,404
-304,744
| -36% | -$7.21M | 0.01% | 935 |
|
|
2021
Q4 | $15.1M | Buy |
852,148
+54,047
| +7% | +$956K | 0.01% | 858 |
|
|
2021
Q3 | $22.5M | Buy |
+798,101
| New | +$22.5M | 0.02% | 653 |
|